CRISPR Therapeutics AG (LON:0VRQ)

London · Delayed Price · Currency is GBP · Price in USD

56.70

-1.27 (-2.20%)

At close: Nov 5, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Genome-editing Technology	37.31M	Log In	Log In	Log In	Log In	Upgrade
Genome-editing Technology Growth	-89.95%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Switzerland and United States	37.31M	Log In	Log In	Log In	Log In	Upgrade
Switzerland and United States Growth	-89.95%	Log In	Log In	Log In	Log In	Upgrade